MedPath

Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults

Not Applicable
Completed
Conditions
Age Problem
Registration Number
NCT04658225
Lead Sponsor
Universidade Federal Fluminense
Brief Summary

The aim of this study will evaluate the effectiveness of 0.12% chlorhexidine solution as an anti-inflammatory agent and reducing the presence of biofilm in young adults.

Detailed Description

Thirty patients with gingivitis ages 18 to 30 year with a probing depth of at most 3 mm and at least 20 teeth will be selected and evaluate at baseline and after 4 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Presence of gingivitis
  • Probing depth (PD) with maximum 3 mm
  • Minimum of 20 teeth
  • Age between 18 and 30 years old
Exclusion Criteria
  • Patients with periodontal disease (PD ≥ 4mm with clinical attachment loss)
  • Diabetes
  • Osteoporosis
  • Pregnant or lactating females
  • Smokers
  • Users of immune suppressive medication
  • Phenytoin or cyclosporine
  • Calcium channel blockers
  • Antibiotics
  • Nonsteroidal anti-inflammatory drugs
  • HIV+ or AIDS

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Plaque Index30 days

Check the biofilm as Ainano \& Bay 1975 index, Higher levels means worse.

Secondary Outcome Measures
NameTimeMethod
Gingival Index30 days

Check the biofilm as Ainano \& Bay 1975 index, Higher levels means worse.

Trial Locations

Locations (1)

Universidade Federal Fluminense

🇧🇷

Nova Friburgo, Rio De Janeiro, Brazil

Universidade Federal Fluminense
🇧🇷Nova Friburgo, Rio De Janeiro, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.